[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1987

Systemic Plasmacytosis and the Crow-Fukase Syndrome

Author Affiliations

Department of Dermatology Bristol Royal Infirmary Bristol BS2 8HW, England

Arch Dermatol. 1987;123(4):425-426. doi:10.1001/archderm.1987.01660280025007
Abstract

To the Editor.—  In the November 1986 issue of the Archives, Watanabe et al1 described two patients with multiple cutaneous plasma cell infiltrates, polyclonal hypergammaglobulinemia, and generalized lymphadenopathy that showed the histologic features of Castleman's giant lymph node hyperplasia. I should like to highlight some similarities between this interesting syndrome and the Crow-Fukase syndrome (also called Shimpo's syndrome, Tatsuki syndrome, PEP syndrome, and POEMS syndrome).2 In the latter syndrome, hyperglobulinemia, which may be polyclonal or monoclonal, is associated with polyneuropathy and a variety of cutaneous and endocrinologic manifestations including edema, pigmentation, scleroderma, gynecomastia, and impotence. Only approximately 50% of cases have evidence of multiple myelomatosis. Generalized lymphadenopathy occurs in the majority of cases, and the lymph nodes often show Castleman's angiofollicular hyperplasia with sheets of mature plasma cells as described by Watanabe and colleagues in their two cases of systemic plasmacytosis. In the Crow-Fukase syndrome, the changes are

First Page Preview View Large
First page PDF preview
First page PDF preview
×